| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd (TEVA) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. TEVA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 367.6K | $11.57M | - | |
| VP | 63.6K | $2.00M | - | |
| Other | 52.8K | $1.66M | - | |
| Other | 52.7K | $1.66M | - | |
| VP | 13.0K | $410.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2020 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 11,472 | $12.14 | $139,295.32 | -10.4% | |
| Feb 14, 2020 | Drape Eric51 | Executive VP Global Operations | Sale+OE | 8,140 | $12.14 | $98,784.60 | -11.8% | |
| Feb 13, 2020 | Sabag Mark | See "remarks" Below | Sale+OE | 72,131 | $13.03 | $939,759.98 | -100% | |
| Feb 10, 2020 | O'Grady Brendan P. | EVP, North America Commercial | Sale+OE | 4,799 | $12.27 | $58,883.73 | -26.3% | |
| Feb 10, 2020 | Nazzi Gianfranco | EVP, Growth Markets Commercial | Sale+OE | 4,155 | $12.24 | $50,864.26 | -18.4% | |
| Feb 10, 2020 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 5,544 | $12.27 | $68,024.88 | -14.3% | |
| Feb 10, 2020 | Drape Eric51 | Executive VP Global Operations | Sale+OE | 3,144 | $12.24 | $38,487.90 | -13.2% | |
| Feb 10, 2020 | Dethlefs Sven | EVP Global Marketing&Portfolio | Sale+OE | 5,669 | $12.27 | $69,558.63 | -23.9% | |
| Feb 10, 2020 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 6,199 | $12.24 | $75,886.30 | -41.9% | |
| Feb 10, 2020 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 12,538 | $12.24 | $153,471.39 | -80.8% |